Calendar

Financial Releases

Date Title  
Toggle Summary AbbVie Reports Fourth-Quarter and Full-Year 2013 Financial Results
- Reports Fourth-Quarter Adjusted EPS of $0.82 (GAAP EPS of $0.70); Reports Full-Year Adjusted EPS of $3.14 (GAAP EPS of $2.56) - Delivers Fourth-Quarter Revenue of $5.1 Billion; Global HUMIRA Sales Growth of 13.4 Percent - Completes Successful First Year as an Independent Company, with Strong
Toggle Summary AbbVie to Host Fourth-Quarter and Full-Year 2013 Earnings Conference Call
NORTH CHICAGO, Ill. , Jan. 13, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2013 financial results on Friday, Jan. 31, 2014 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie to Present at 32nd Annual J.P. Morgan Healthcare Conference
NORTH CHICAGO, Ill. , Dec. 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 32 nd Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 15, 2014 . Bill Chase , executive vice president and chief financial officer, will make a formal presentation on the company at 11 a.m.
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Dec. 12, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.40 per share.  The cash dividend is payable Feb. 14, 2014 to stockholders of record at the close of business on Jan. 15, 2014 .
Toggle Summary AbbVie to Present at Jefferies 2013 Healthcare Conference
NORTH CHICAGO, Ill. , Nov. 14, 2013 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Jefferies 2013 Healthcare Conference on Thursday, Nov. 21, 2013 . Scott Brun , M.D., vice president, pharmaceutical development, will take part in a question and answer session at 10:40 a.m.
Toggle Summary AbbVie to Present at Credit Suisse 2013 Healthcare Conference
NORTH CHICAGO, Ill , Nov. 7, 2013 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Credit Suisse 2013 Healthcare Conference on Thursday, Nov. 14, 2013 . Bill Chase , executive vice president and chief financial officer, and Scott Brun , M.D., vice president, pharmaceutical development,
Toggle Summary AbbVie Reports Third-Quarter 2013 Financial Results
NORTH CHICAGO, Ill. , Oct. 25, 2013 /PRNewswire/ -- Reports Third-Quarter Adjusted EPS of $0.82 , Above Previous Guidance Range ; GAAP EPS of $0.60 Raises 2013 Adjusted EPS Guidance to $3.11-$3.13 , GAAP EPS Guidance of $2.54-$2.56 Delivers Revenue of $4.658 Billion , an Increase of 3.3 Percent (Up
Toggle Summary AbbVie to Host Third-Quarter Earnings Conference Call
NORTH CHICAGO, Ill. , Oct. 4, 2013 /PRNewswire/ --  AbbVie (NYSE: ABBV) will announce its third-quarter 2013 financial results on Friday, Oct. 25, 2013 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m. Eastern).
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 19, 2013 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.40 per share.  The cash dividend is payable Nov. 15, 2013 to stockholders of record at the close of business on Oct. 15, 2013 .
Toggle Summary AbbVie to Present at Morgan Stanley Global Healthcare Conference
NORTH CHICAGO, Ill. , Aug. 27, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 10, 2013 . Richard A. Gonzalez , chairman and chief executive officer, and Scott Brun , M.D., vice president, pharmaceutical development,